LONG EGF, REPLIGEN

Brands
REPLIGEN
Short Description

Recombinant human EGF analog for cell culture, animal-free.

Description

LONG® EGF is a recombinant analog of human epidermal growth factor that enhances mammalian cell cultures through receptor-specific activation of the ErbB-1 pathway, triggering mitogenic signalling that promotes cell division, survival and metabolic activity. It works synergistically with LONG® R³ IGF-I, improving proliferation and cell density in HEK293, MDCK and HeLa cultures, and maintains activity in chemically defined, serum-free media while minimising oxidative stress and apoptosis.

This animal-free recombinant protein is manufactured by proprietary E. coli fermentation to ISO 9001 standards with high purity and batch-to-batch consistency suitable for therapeutic applications. Available as lyophilised powder in 1 mg and 20 mg formats, it is a direct replacement for native human or murine EGF across fibroblast, epithelial and keratinocyte systems and supports cell-based vaccine production.

Industry
  • Biopharma
  • Pharmaceutical
Search for a city or select popular from the list
Share
Click on the image to refresh the captcha.